These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Seizure recurrence following pyridoxine withdrawal in a patient with pyridoxine-dependent epilepsy. Tamaura M; Shimbo H; Iai M; Yamashita S; Osaka H Brain Dev; 2015 Apr; 37(4):442-5. PubMed ID: 25123644 [TBL] [Abstract][Full Text] [Related]
17. Alpha-aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by alpha-aminoadipic semialdehyde dehydrogenase deficiency. Struys EA; Jakobs C Mol Genet Metab; 2007 Aug; 91(4):405. PubMed ID: 17560822 [No Abstract] [Full Text] [Related]
18. Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option. Pérez B; Gutiérrez-Solana LG; Verdú A; Merinero B; Yuste-Checa P; Ruiz-Sala P; Calvo R; Jalan A; Marín LL; Campos O; Ruiz MÁ; San Miguel M; Vázquez M; Castro M; Ferrer I; Navarrete R; Desviat LR; Lapunzina P; Ugarte M; Pérez-Cerdá C Epilepsia; 2013 Feb; 54(2):239-48. PubMed ID: 23350806 [TBL] [Abstract][Full Text] [Related]
19. A case of extreme prematurity and delayed diagnosis of pyridoxine-dependent epilepsy. Al-Saman AS; Rizk TM Neurosciences (Riyadh); 2012 Oct; 17(4):371-3. PubMed ID: 23022904 [TBL] [Abstract][Full Text] [Related]